Hidden Road Launches Digital Asset Swaps Prime Brokerage for the United States Market
New Product Launch Expands Suite of Prime Brokerage Solutions and Fulfills Growing U.S. Demand for Digital Asset Swaps
LONDON, May 28, 2025 /PRNewswire/ -- Hidden Road today announced the launch of its digital asset swaps prime brokerage capabilities for the United States market. U.S.-based institutional clients will now be able to execute cash-settled OTC swaps across dozens of the most prominent digital assets.
The new OTC swaps product is offered from the Group's FCA-regulated entity, Hidden Road Partners CIV UK Ltd. With this launch, Hidden Road will also offer various cross-margining and financing services in digital assets.
'The United States digital asset market has long been under-served from a product standpoint,' said Michael Higgins, International CEO and Global Head of Corporate Development for Hidden Road. 'While OTC swaps represent a significant portion of digital asset trading volumes globally, until now, they were largely unavailable to U.S. institutions. With the launch of our swap prime brokerage capabilities for the United States market, we can provide clients with access to an expanded range of products and solutions.'
The launch of Hidden Road's digital asset swap capabilities for the United States follows its definitive agreement in April 2025 to be acquired by Ripple, a leading provider of digital asset infrastructure for financial institutions, for $1.25 billion. With the backing of Ripple's significant balance sheet, Hidden Road will exponentially expand its capacity to service its pipeline and become one of the largest non-bank prime brokers globally. The deal is expected to close in the coming months, subject to regulatory approvals.
About Hidden Road
Hidden Road Partners is the global credit network for institutions, enabling seamless access to traditional and digital markets. Conflict-free and built on a modern technology stack, we remove complexity and cost in prime brokerage, clearing and financing. For more information, please email [email protected].
Media Contact
Carissa Felger/Sam Fisher
Gasthalter & Co.
[email protected]
+1 (212) 257-4170
View original content to download multimedia: https://www.prnewswire.com/news-releases/hidden-road-launches-digital-asset-swaps-prime-brokerage-for-the-united-states-market-302466322.html
SOURCE Hidden Road Partners
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Ethical Web AI Launches AI Vault SaaS on AWS Marketplace
NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Bubblr Inc., doing business as Ethical Web AI (OTC: BBLR), a leader in enterprise-specific generative AI, is proud to announce the launch of AI Vault SaaS on the AWS Marketplace. This new software-as-a-service version of AI Vault marks a major milestone for the company, dramatically simplifying deployment and expanding market accessibility. AI Vault Enterprise—Ethical Web AI's original flagship solution—requires integration into a client's AWS environment, often involving time and DevOps resources. While larger enterprises may accommodate this with ease, smaller companies and those seeking to trial the product may find it a barrier to adoption. The new AI Vault SaaS eliminates this friction. Now available directly via the AWS Marketplace, it allows businesses to deploy instantly without needing to configure their cloud infrastructure. This significantly shortens the sales cycle and makes it easy for companies of all sizes to experience AI Vault's capabilities firsthand. 'The launch of AI Vault SaaS is a game-changer,' said Steve Morris, CTO and Founder of Ethical Web AI. 'Amazon's support has been phenomenal throughout this process. Our recent accreditation as an AWS Software Partner has been one of the most significant milestones in our history. It's enabled us to deliver both versions of AI Vault through the AWS Marketplace and unlock powerful co-marketing opportunities.' AI Vault SaaS is priced at $20 per user, slightly higher than the $15 per user cost of AI Vault Enterprise due to Ethical Web AI absorbing the full computational workload. Despite this, both offerings remain more cost-effective than typical generative AI competitors, offering significantly greater enterprise control and transparency. The company expects to onboard its first five clients within the next week, a milestone that will activate expanded AWS co-marketing support and signal the start of a full-scale commercial push through direct sales and reseller partnerships. About AI VaultAI Vault is a groundbreaking generative AI platform engineered for enterprises that prioritise security, privacy, and control. With 27% of global businesses—especially financial institutions and highly regulated organisations—hesitant to adopt generative AI due to data concerns, AI Vault provides a trusted alternative. The platform offers: Full control and visibility over AI interactions within the organisation Zero data sharing with Ethical Web AI or any third-party LLM partners Protection through three USPTO patents, including a key patent that guarantees client data never leaves their environment Watch the explainer video to see AI Vault in action: AI Vault Explainer Video ( About Ethical Web AIEthical Web AI is a mission-driven technology company advocating for a safer, more transparent internet. Our patented generative AI solutions are designed to empower enterprises with the tools they need to innovate confidently—without compromising ethics, privacy, or security. Safe Harbor StatementThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management. They are subject to several uncertainties and risks that could significantly affect the Company's current plans and expectations, future operations, and financial condition. The Company reserves the right to update or alter its forward-looking statements, whether due to new information, future events or otherwise. Media and investor contact:
Yahoo
an hour ago
- Yahoo
Should You Buy the Dip on XRP?
After soaring to a 52-week high in January, XRP is now down 35%. The most important near-term catalyst for XRP is imminent SEC approval of new spot ETFs. XRP has seen a significant decline in transaction activity over the past two months, raising questions about its future growth potential. 10 stocks we like better than XRP › Heading into 2025, XRP (CRYPTO: XRP) was the hottest crypto on the planet. But after hitting a 52-week high of $3.39 in January, XRP has fizzled out. It's now down 35% from its 2025 peak, and investors are understandably concerned. Is now the time to buy the dip on XRP? Or is your money better spent elsewhere? Let's take a closer look. Heading into November, XRP had basically flatlined at the $0.50 price level. However, after the presidential election, it suddenly surged, eventually reaching a multi-year high. This makes sense, of course, because XRP was the one cryptocurrency destined to get the biggest bounce from a pro-crypto Trump presidency. Up until November, dark regulatory clouds were hanging over Ripple, the company behind the XRP token. The Securities and Exchange Commission (SEC) claimed that XRP was a "security" and not a "commodity." This asset class is subject to stricter regulations regarding trading, ownership, and reporting requirements. However, as soon as Trump was elected, XRP skyrocketed. The logic was simple: a Trump presidency would likely lead to a shakeup at the SEC, which would then help lift all the regulatory clouds hanging over Ripple and XRP. And that's exactly what happened. The problem is that this development has been replaced by a new narrative around global trade and tariffs. All of last year's pro-crypto euphoria has already been priced into XRP, and investors are looking for a new narrative to drive XRP higher. The most likely new catalyst is SEC approval of spot XRP exchange-traded funds (ETFs). Already, there are several spot XRP ETF applications in the pipeline, including ones from Franklin Templeton (NYSE: BEN) and WisdomTree (NYSE: WT). The thinking here is that a new pro-crypto approach at the SEC will give it the freedom to sign off on at least one of these ETF applications. The timing has been pushed back to the fourth quarter (Q4), but prediction markets are giving this a 93% chance of happening by the end of 2025. It's almost just a matter of "when," not "if." If the success of the spot Bitcoin ETFs is any guide, then these new spot XRP ETFs could result in a tsunami of new investor money flooding into XRP, helping to push up its price. As further proof of just how mainstream XRP has become, some publicly traded companies are now thinking about adding XRP as a treasury asset to their balance sheets. This is a strategy that was first popularized with Bitcoin (CRYPTO: BTC), and now it looks like the same strategy could be coming for XRP as well. One example is sustainable energy producer VivoPower International (NASDAQ: VVPR), which plans to buy $100 million of XRP for its treasury. And a Chinese company recently filed with the SEC to buy $300 million of XRP for its treasury. It remains to be seen if other companies will follow their lead, but XRP bulls are understandably enthusiastic about this development. The coin was never meant to serve as a long-term value storage system, but XRP investors aren't complaining about this new idea. That's the good news. The bad news, unfortunately, is that usage of the XRP token has fallen off a cliff over the past two months. As demand for XRP falls, it means that there will likely be downward pressure on its price. Keep in mind: XRP is essentially a bridge currency. That means it's primarily used to facilitate cross-border payments and transfer value between different fiat currencies. Typically, users convert one fiat currency into XRP, send it across the XRP blockchain to a user in another country, who then converts it into another fiat currency. It might sound complex, but it's cheaper and more efficient than using traditional finance tools. However, now that global trade has been turned upside down, the growing consensus is that XRP may no longer be as needed as it once was. After all, who's sending money across borders these days? That could help to explain why the fall in demand for XRP has been so dramatic over the past two months. This time period lines up perfectly with the announcement of the Liberation Day tariffs on April 2. Moreover, there appears to be another factor at work here, and that's the emergence of stablecoins as yet another way to send cross-border payments. Stablecoins are now a $250 billion industry, and it's clear that they are here to stay. In fact, Ripple recently launched a stablecoin of its own. While it was originally intended to help stoke demand for XRP, this stablecoin could end up cannibalizing some of the transaction activity of XRP, further reducing demand for the token. And that, of course, is going to further keep a lid on future price gains for XRP. In fact, a growing number of investors are now warning that XRP could drop below the $2 mark soon. The decision of whether or not to buy XRP is more complicated than you might think. While there are definitely near-term catalysts waiting to send XRP higher, it all comes amid a backdrop of macroeconomic uncertainty. Thus, before you decide to buy XRP, you need to be comfortable with the current situation involving global trade and tariffs. Even though XRP has enormous upside potential going forward, it may continue to trade sideways until the tariff situation is resolved once and for all. Before you buy stock in XRP, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and XRP wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,538!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $869,841!* Now, it's worth noting Stock Advisor's total average return is 789% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Dominic Basulto has positions in Bitcoin and XRP. The Motley Fool has positions in and recommends Bitcoin and XRP. The Motley Fool recommends WisdomTree. The Motley Fool has a disclosure policy. Should You Buy the Dip on XRP? was originally published by The Motley Fool
Business Wire
3 hours ago
- Business Wire
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
LAVAL, Quebec--(BUSINESS WIRE)--Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) ('Crescita' or the 'Company'), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced the voting results from its Annual General and Special Meeting of Shareholders held at its corporate headquarters in Laval, Quebec on June 4, 2025. The detailed results of the votes received by proxy are as follows: Election of Directors Director Nominees NUMBER OF SHARES PERCENTAGE OF VOTES CAST FOR WITHHELD FOR WITHHELD Daniel N. Chicoine 5,432,232 301,172 94.75% 5.25% Anthony E. Dobranowski 5,455,219 278,185 95.15% 4.85% John C. London 5,427,266 306,138 94.66% 5.34% Deborah Shannon-Trudeau 5,463,225 270,179 95.29% 4.71% Serge Verreault 5,490,982 242,422 95.77% 4.23% Expand Reappointment of External Auditors Outcome NUMBER OF SHARES PERCENTAGE OF VOTES CAST FOR WITHHELD FOR WITHHELD Ernst & Young LLP reappointed 6,388,758 49,767 99.23% 0.77% Expand Approval of the Continuation of Crescita's Shareholder Rights Plan Outcome NUMBER OF SHARES PERCENTAGE OF VOTES CAST FOR AGAINST FOR AGAINST Shareholder Rights Plan approved 5,481,368 252,036 95.60% 4.40% Expand About Crescita Therapeutics Inc. Crescita (TSX: CTX and OTC US: CRRTF) is a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house R&D and manufacturing capabilities. The Company offers a portfolio of high-quality, science-based non-prescription skincare products and a commercial stage prescription product. We also own multiple proprietary transdermal delivery platforms that support the development of patented formulations to facilitate the delivery of active ingredients into or through the skin. For more information visit, Source: Crescita Therapeutics
